Two Distinct Types of Hypercontractile Esophagus: Classic and Spastic Jackhammer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Hypercontractile esophagus (nicknamed jackhammer esophagus) is a recently defined disease within the esophageal motility disorders classification. Responses to treatments for jackhammer esophagus have been inconsistent in previous trials, possibly due to its heterogeneous manifestation. Thus, we reviewed 10 patients diagnosed with jackhammer esophagus and compared their clinical and manometric features at baseline. Additionally, manometric and symptomatic responses after treatment with known smooth muscle relaxants, including anticholinergic drugs (cimetropium bromide and scopolamine butylbromide) and a phosphodiesterase-5 inhibitor (sildenafil) were compared. We observed two distinct subgroups in the findings: one with hypercontractility and normal distal latencies (“classic jackhammer esophagus,” n=7) and the other with hypercontractility and short distal latencies (“spastic jackhammer esophagus,” n=3). The two types also differed in their responses to medications in that symptoms improved upon treatment with an anticholinergic agent in classic jackhammer esophagus patients, while spastic jackhammer esophagus was unresponsive to both the anticholinergic drugs and the phosphodiesterase-5 inhibitor. In conclusion, hypercontractile esophagus may be a heterogeneous disease with different underlying pathophysiologies. We introduced two novel terms, “classic jackhammer esophagus” and “spastic jackhammer esophagus,” to distinguish the two types.
Abstract
Hypercontractile esophagus (nicknamed jackhammer esophagus) is a recently defined disease within the esophageal motility disorders classification. Responses to treatments for jackhammer esophagus have been inconsistent in previous trials, possibly due to its heterogeneous manifestation. Thus, we reviewed 10 patients diagnosed with jackhammer esophagus and compared their clinical and manometric features at baseline. Additionally, manometric and symptomatic responses after treatment with known smooth muscle relaxants, including anticholinergic drugs (cimetropium bromide and scopolamine butylbromide) and a phosphodiesterase-5 inhibitor (sildenafil) were compared. We observed two distinct subgroups in the findings: one with hypercontractility and normal distal latencies (“classic jackhammer esophagus,” n=7) and the other with hypercontractility and short distal latencies (“spastic jackhammer esophagus,” n=3). The two types also differed in their responses to medications in that symptoms improved upon treatment with an anticholinergic agent in classic jackhammer esophagus patients, while spastic jackhammer esophagus was unresponsive to both the anticholinergic drugs and the phosphodiesterase-5 inhibitor. In conclusion, hypercontractile esophagus may be a heterogeneous disease with different underlying pathophysiologies. We introduced two novel terms, “classic jackhammer esophagus” and “spastic jackhammer esophagus,” to distinguish the two types.
참고문헌 (18)
- Spechler SJ, "Classification of oesophageal motility abnormalities", Gut, 49, pp.145~151 (2001)
- Bredenoord AJ, "Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography", Neurogastroenterol Motil, 24(1), pp.57~65 (2012)
- Roman S, "Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT)", Am J Gastroenterol, 107, pp.37~45 (2012)
- Cattau EL Jr, "Diltiazem therapy for symptoms associated with nutcracker esophagus", Am J Gastroenterol, 86, pp.272~276 (1991)
- Korsapati H, "Reversal of asynchrony between circular and longitudinal muscle contraction in nutcracker esophagus by atropine", Gastroenterology, 135, pp.796~802 (2008)
- Marjoux S, "Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases?", Dis Esophagus, 28, pp.735~741 (2015)
- Lee JI, "The effect of sildenafil on oesophageal motor function in healthy subjects and patients with nutcracker oesophagus", Neurogastroenterol Motil, 15, pp.617~623 (2003)
- Dogan I, "Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms", Am J Gastroenterol, 102, pp.137~145 (2007)
- Kahrilas PJ, "The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry", Gastroenterology, 145, pp.954~965 (2013)
- Goyal RK, "Physiology of normal esophageal motility", J Clin Gastroenterol, 42, pp.610~619 (2008)
- Conklin JL, "Nitric oxide: a mediator of esophageal motor function", J Lab Clin Med, 131, pp.10~20 (1998)
- Gyawali CP, "Evaluation of esophageal motor function in clinical practice", Neurogastroenterol Motil, 25, pp.99~133 (2013)
- Roman S, "Distal contraction latency:a measure of propagation velocity optimized for esophageal pressure topography studies", Am J Gastroenterol, 106, pp.443~451 (2011)
- Lin Z, "Refining the criterion for an abnormal Integrated Relaxation Pressure in esophageal pressure topography based on the pattern of esophageal contractility using a classification and regression tree model", Neurogastroenterol Motil, 24, pp.e356~e363 (2012)
- Roman S, "The Chicago classification of motility disorders: an update", Gastrointest Endosc Clin N Am, 24, pp.545~561 (2014)
- Samuels LA, "Pharmacotherapy update: hyoscine butylbromide in the treatment of abdominal spasms", Clin Med Ther, 1, pp.647~655 (2009)
- Nichols DJ, "Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality", Br J Clin Pharmacol, 53(1), pp.5S~12S (2002)
- Gupta M, "The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction", J Clin Pharmacol, 45, pp.987~1003 (2005)